MeOmics Precision Medicine
MeOmics is a Cardiff University spin-out company who have created a physiological assay for psychiatric diseases using a combination of artificial intelligence and stem cells to predict a patient's response to a drug therapy. This platform has application in drug discovery as a preclinical screening assay, and may have future application in diseases diagnosis and personalised medicine.